Contact
searchSearch
HMP Global

Seizure Topic Center

Industry Insights
News

news


News
Antiseizure Drugs for Tumor-Related Epilepsy Require Careful Management
12/04/2024
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review...
12/04/2024
First Report Managed Care
News
Algorithm Predicts Seizure Control Outcomes After Brain Resection Surgery
12/03/2024
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm...
12/03/2024
First Report Managed Care
News

Assessment of Individual Risk for Epilepsy After CVT Using the DIAS3 Score
11/20/2024
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and...
11/20/2024
First Report Managed Care
News
Clinical Predictors of One-Year Seizure Freedom After SLAH
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
Poststroke Seizure Care Differs With Time of Occurrence
10/18/2024
A common complication of stroke, poststroke seizures require a systematic diagnosis, according to a review article in Frontiers in Neurology.
A common complication of stroke, poststroke seizures require a systematic diagnosis, according to a review article in Frontiers in Neurology.
A common complication of stroke,...
10/18/2024
First Report Managed Care
News
TBI Before or Soon After Epilepsy Diagnosis Associated With Increased Mortality Risk
10/07/2024
Mortality was significantly higher among post-9/11 military veterans with epilepsy who had a traumatic brain injury (TBI) before epilepsy or who experienced a TBI within 6 months of their epilepsy diagnosis, according to a study published...
Mortality was significantly higher among post-9/11 military veterans with epilepsy who had a traumatic brain injury (TBI) before epilepsy or who experienced a TBI within 6 months of their epilepsy diagnosis, according to a study published...
Mortality was significantly...
10/07/2024
First Report Managed Care
News
Febrile Seizure Risk Slightly Higher With Vaccine Combinations in Kids
06/08/2016
By Will Boggs MD NEW YORK (Reuters Health) - The risk of febrile seizures in children increases slightly when trivalent inactivated influenza vaccine (IIV3) is given in combination with pneumococcal conjugate vaccine (PCV) or a...
By Will Boggs MD NEW YORK (Reuters Health) - The risk of febrile seizures in children increases slightly when trivalent inactivated influenza vaccine (IIV3) is given in combination with pneumococcal conjugate vaccine (PCV) or a...
By Will Boggs MD NEW YORK...
06/08/2016
First Report Managed Care
News
Cannabidiol Drug Reduces Seizure Rate in New Study
03/18/2016
In a Phase III trial, the investigational medicine Epidiolex (cannabidiol, GW Pharmaceuticals plc) performed significantly better than placebo in reducing convulsive seizures in children with Dravet syndrome, a rare and severe form of...
In a Phase III trial, the investigational medicine Epidiolex (cannabidiol, GW Pharmaceuticals plc) performed significantly better than placebo in reducing convulsive seizures in children with Dravet syndrome, a rare and severe form of...
In a Phase III trial, the...
03/18/2016
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Conference Coverage
Exploring the Biosimilar Regulatory Landscape and Future Marketplace Potential
04/14/2023
Presenters at AMCP 2023 examined the regulatory landscape of biosimilars in the United States, explored key influencers for the adoption, and outlined the practical considerations for use.
Presenters at AMCP 2023 examined the regulatory landscape of biosimilars in the United States, explored key influencers for the adoption, and outlined the practical considerations for use.
Presenters at AMCP 2023 examined...
04/14/2023
First Report Managed Care
News
Montana Passes Significant Health Policy Changes
05/05/2023
A recent legislative session in Montana included notable policy changes for Medicaid reimbursement, abortion, transgender rights, behavioral health, and more. 
A recent legislative session in Montana included notable policy changes for Medicaid reimbursement, abortion, transgender rights, behavioral health, and more. 
A recent legislative session in...
05/05/2023
First Report Managed Care
Headshot of David Rosmarin, Tufts, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
JAK Inhibitor Results in Skin Repigmentation in Patients With Vitiligo
05/30/2023
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair...
05/30/2023
First Report Managed Care
News
Patient Access, Inspection Challenges Arise as Generic Oncology Drug Production Decreases
06/23/2023
An ongoing decline in generic oncology drug production has created medication access difficulties for US patients.
An ongoing decline in generic oncology drug production has created medication access difficulties for US patients.
An ongoing decline in generic...
06/23/2023
Pharmacy Learning Network
Quiz
Key Features of RSV mRNA Vaccine Development
07/21/2023
What is a key feature of the RSV mRNA vaccine that must be accounted for in the vaccine development process? 
What is a key feature of the RSV mRNA vaccine that must be accounted for in the vaccine development process? 
What is a key feature of the RSV...
07/21/2023
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use